Jaime Rodriguez‐Canales
Erasmus Hospital(BE)Fundación Cardiovascular de Colombia(CO)AstraZeneca (United States)(US)Daiichi Sankyo (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, RNA modifications and cancer, Lung Cancer Treatments and Mutations, Radiomics and Machine Learning in Medical Imaging, Cancer Genomics and Diagnostics
Most-Cited Works
- → STK11/LKB1 Mutations and PD-1 Inhibitor Resistance in KRAS-Mutant Lung Adenocarcinoma(2018)1,562 cited
- → Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial(2017)1,375 cited
- → Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma(2018)682 cited
- → Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer(2005)618 cited
- → A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition(2015)576 cited
- → Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5